loading...| Preferred Name |
Essential thrombocythemia |
| ID |
http://www.orpha.net/ORDO/Orphanet_3318 |
| alternative_term |
Essential thrombocytosis ET |
| definition |
Essential thrombocythemia (ET) is a myeloproliferative neoplasm (MPN, see this term) characterized by a sustained elevation of platelet number (> 450 x 109/L) with a tendency for thrombosis and hemorrhage. |
| definition_citation |
Orphanet |
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=3318 |
| has_age_of_onset |
All ages |
| has_inheritance |
Not applicable Multigenic/multifactorial |
| hasDbXref |
UMLS:C0040028 OMIM:187950 ICD-11:3B63.1Z OMIM:601977 ICD-10:D47.3 MeSH:D013920 MedDRA:10015493 OMIM:614521 |
| label |
Essential thrombocythemia |
| notation |
ORPHA:3318 |
| part_of | |
| prefixIRI |
ORDO:Orphanet_3318 |
| prefLabel |
Essential thrombocythemia |
| present_in |
Sweden AND has_annual_incidence_average_value : 1.55 AND has_annual_incidence_range : 1-9 / 100 000 United States AND has_point_prevalence_average_value : 24.0 AND has_point_prevalence_range : 1-5 / 10 000 Sweden AND has_point_prevalence_average_value : 30.0 AND has_point_prevalence_range : 1-5 / 10 000 Europe AND has_point_prevalence_range : 1-5 / 10 000 Europe AND has_annual_incidence_average_value : 0.48 AND has_annual_incidence_range : 1-9 / 1 000 000 |
| treeView | |
| subClassOf |